How can we make advanced metabolomics accessible for routine clinical use — at an affordable cost — in service of the greater good of prevention and personalized medicine?

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

 

Earlier this year at Arab Health in Dubai, Ali Tinazli spoke about our work at Lifespin GmbH and how our General Health Assessment (GHA) supports that goal.

This short interview highlights:
• Why metabolomic data matters for understanding real-time physiological health
• How our NMR-based platform enables broad, non-invasive access to insight
• What it means to turn complex biology into practical tools for everyday care

Our aim is simple: bring meaningful health information to more people, earlier — not for the sake of novelty, but because better prevention should serve the greater good, not just a privileged few.

🎬 The interview was recorded in January — the message remains timely.

#Lifespin #Metabolomics #PrecisionMedicine #PreventiveCare #DigitalDiagnostics #GHA #HealthEquity #PopulationHealth #ArabHealth #MadeInGermany #GreaterGood #AccessibleInnovation

More from press and media

Scroll to Top
video-thumb

Dr. Roland Geyer

COO
10+ years experience in NMR-based metabolomics and diagnostic.

Dr. Renate Kirchhöfer

CDO & Co-Founder
20+ years developing NMR-applications and bringing them to regulated markets.

Dr. Fritz Huber

CEO & Co-Founder
20+ years developing and marketing NMR-based assays—he is a pioneer in this field.

Dr. Ali Tinazli

CEO, lifespin GmbH

15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).